St-N, a novel alkaline derivative of stevioside, reverses docetaxel resistance by targeting lysosomes in vitro and in vivo.
Drug resistance of cancers remains a major obstacle due to limited therapeutics. Lysosome targeting is an effective method for overcoming drug resistance in cancer cells. St-N (ent-13-hydroxy-15-kaurene-19-acid N-methylpiperazine ethyl ester) is a novel alkaline stevioside derivative with an amine g...
Saved in:
Main Authors: | Yanxia Guo, Shikang Wang, Qun Liu, Yan Dong, Yongqing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0316268 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel
by: Filippo Francini, et al.
Published: (2011-01-01) -
Lutein-stevioside nanoparticle attenuates H2O2-induced oxidative damage in ARPE cells
by: Zhuqing Dai, et al.
Published: (2024-05-01) -
Stevioside mitigates metabolic dysregulation in offspring induced by maternal high-fat diet: the role of gut microbiota-driven thermogenesis
by: Jin Ye, et al.
Published: (2025-12-01) -
Saussurea gossypiphora extracts reduce inflammation by reversing inflammatory cytokine levels in in-vitro and in-vivo
by: Kalyani Jatoth, et al.
Published: (2025-02-01) -
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
by: Youmei Xiao, et al.
Published: (2025-02-01)